Protein levels of SV2A and VGLUT1 in brain tissue from patients with Parkinson’s disease, dementia with Lewy bodies and Alzheimer’s disease
Objective: The objective of this study was to investigate whether SV2A and/or VGLUT1 are suitable as markers for synaptic degeneration in neurodegenerative disorders and could…Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up
Objective: To investigate the impact of cognition and cognitive decline on quality of life (QoL) in an incident Parkinson's disease (PD) cohort over three years.…Heart rate variability to differentiate dementia with Lewy bodies from Alzheimer’s disease in patients with mild cognitive impairment
Objective: We aimed to determine whether heart rate variability (HRV) can aid in the differentiation of DLB from AD at the MCI stage. Background: Mild…Neuron specific protein S100B and cognitive impairment in various forms parkinsonism
Objective: In Parkinson's disease (PD) in almost all patients at the early stages of developing cognitive impairment. Background: Study of the degree of cognitive impairment,…The effects of deep brain stimulation for Parkinson’s disease on cognition and perceived quality of life: Preliminary results from an Ecuadorian sample
Objective: To evaluate the effects of deep brain stimulation (DBS) on cognition and perceived quality of life in the first cohort of patients undergoing DBS…Sensitivity of people with Parkinson’s to different intensities of emotions (SPiEs)
Objective: To characterise the ability of individuals with Parkinson's to discriminate the six universal facial expressions. Background: People with Parkinson's (PwP) tend to have difficulty…Effects of gender, age and hyposmia on cognitive functions in healthy elderly individuals at risk for Parkinson’s disease: Results from the TREND study
Objective: To evaluate the impact of gender, age and hyposmia on the cognitive performance in memory, language, executive, and visuo-spatial functions to set the stage…Cognitive complaint in Parkinson’s disease patients with normal cognition
Objective: To characterize cognitively normal PD patients who endorse cognitive complaint, and to assess their cognitive performance over time. Background: PD patients are at a…Symptom progression in a large cohort of Parkinson’s disease cases in a clinical practice setting
Objective: To assess the temporal profile of motor and non-motor symptoms in Parkinson's disease. Background: Parkinson's disease is characterized by varying combinations of motor and…Creative thinking and parkinsonism: Preliminary clinical data on the role of frontal area
Objective: To evaluate divergent thinking (DT) by means of Abbreviated Torrance Test for Adults (ATTA) in Parkinsonism (PKS) with different deficit in cognitive functions. Background:…
- « Previous Page
- 1
- …
- 107
- 108
- 109
- 110
- 111
- …
- 117
- Next Page »